Knoll Capital Management, LLC has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $150 Million distributed in 36 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Aldeyra Therapeutics, Inc. with a value of $31.5M, Biohaven Pharmaceutical Holding CO Ltd. with a value of $20M, Entera Bio Ltd. with a value of $10M, Spdr Gold Trust with a value of $9.22M, and Meira G Tx Holdings PLC with a value of $8.48M.

Examining the 13F form we can see an decrease of $5.26M in the current position value, from $155M to 150M.

Knoll Capital Management, LLC is based out at Miami, FL

Below you can find more details about Knoll Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $150 Million
Healthcare: $91.9 Million
Basic Materials: $38.5 Million
ETFs: $12.9 Million
Industrials: $2.47 Million
Consumer Defensive: $2.29 Million
Financial Services: $1.7 Million

Stock Holdings Table Market Cap. of $10 Billions to $200 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 36
  • Current Value $150 Million
  • Prior Value $155 Million
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 4 stocks
  • Additional Purchases 2 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1 stocks
Track This Portfolio

Track Knoll Capital Management, LLC Portfolio

Follow Knoll Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Knoll Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Knoll Capital Management, LLC with notifications on news.